510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K874623Substantially Equivalent

Fiagen(tm) Thyroxine (T4), Catalogue #101-101

Cyberfluor, Inc., Ontario M5t 1x4, CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K874623 is the FDA 510(k) clearance record for FIAGEN(TM) THYROXINE (T4), CATALOGUE #101-101, a class II device, cleared for Cyberfluor, Inc. on under FDA product code CDX (Radioimmunoassay, Total Thyroxine). FDA records list 17 510(k) clearances for Cyberfluor, Inc., from to . As of , FDA records show no recalls naming K874623.

Clearance record

Decision date
Received
(98 days to decision)
Product code
CDX Radioimmunoassay, Total Thyroxine
Regulation
21 CFR 862.1700
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Cyberfluor, Inc. 179 John St., 4th Floor ,, Ontario M5t 1x4, CA
Third party review
No

Clearances, product code CDX

Trailing 12 months

FDA records hold no clearances under product code CDX in the trailing twelve months.

FDA records show no clearances under product code CDX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code CDX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260